6016

COM:SPHCHINA

上海医药

  • Stock

Last Close

22.07

22/11 07:00

Market Cap

56.32B

Beta: -

Volume Today

29.86M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
10.40B
-
12.04B
15.76%
14.09B
17.00%
15.75B
11.81%
16.84B
6.92%
21.15B
25.55%
24.95B
17.99%
24.48B
1.88%
25.60B
4.55%
30.78B
20.26%
35.54B
15.46%
average payables
15.73B
-
18.66B
18.64%
22.44B
20.26%
25.21B
12.37%
26.64B
5.67%
31.22B
17.20%
36.01B
15.34%
37.33B
3.67%
39.89B
6.86%
46.78B
17.26%
49.74B
6.33%
average receivables
16.59B
-
20.89B
25.91%
25.75B
23.28%
29.44B
14.32%
33.20B
12.77%
41.87B
26.12%
51.13B
22.13%
56.93B
11.34%
62.90B
10.49%
71.26B
13.28%
78.82B
10.61%
book value per share
9.65
-
10.35
7.20%
11.13
7.58%
11.76
5.66%
12.66
7.62%
13.77
8.82%
14.70
6.74%
15.94
8.42%
17.35
8.84%
19.22
10.81%
18.51
3.68%
capex per share
-0.34
-
-0.48
42.70%
-0.64
33.21%
-0.79
23.18%
-0.75
5.28%
-0.69
8.12%
-0.97
41.63%
-1.06
8.88%
-1.45
36.85%
-0.77
46.84%
-0.80
4.29%
capex to depreciation
-1.65
-
-2.21
34.09%
-2.56
15.87%
-2.84
11.04%
-2.39
15.87%
-1.66
30.47%
-1.46
12.09%
-1.41
3.60%
-1.92
36.71%
-1.21
37.24%
-1.26
4.14%
capex to operating cash flow
-0.93
-
-0.97
4.00%
-1.28
31.88%
-1.09
14.63%
-0.76
30.39%
-0.62
18.21%
-0.46
26.24%
-0.44
3.81%
-0.81
85.05%
-0.57
30.44%
-0.48
15.55%
capex to revenue
-0.01
-
-0.01
20.80%
-0.02
16.65%
-0.02
7.63%
-0.02
12.58%
-0.01
20.38%
-0.01
20.82%
-0.02
6.29%
-0.02
21.67%
-0.01
39.35%
-0.01
1.11%
cash per share
4.83
-
4.32
10.56%
4.48
3.71%
4.45
0.57%
5.52
23.99%
6.09
10.38%
5.92
2.76%
7.40
24.98%
7.43
0.38%
10.61
42.75%
10.99
3.57%
days of inventory on hand
59.04
-
58.98
0.10%
59.41
0.72%
56.24
5.33%
55.23
1.79%
66.90
21.13%
56.84
15.04%
53.46
5.95%
52.82
1.18%
62.42
18.17%
57.99
7.11%
days payables outstanding
90.61
-
92.09
1.64%
96.20
4.46%
89.03
7.45%
87.30
1.95%
93.97
7.64%
84.25
10.35%
83.87
0.45%
81.85
2.41%
93.41
14.13%
75.87
18.78%
days sales outstanding
84.78
-
93.25
9.98%
96.50
3.48%
93.64
2.96%
98.79
5.50%
110.88
12.23%
105.54
4.81%
113.97
7.99%
111.43
2.23%
120.58
8.21%
113.91
5.53%
debt to assets
0.11
-
0.13
16.59%
0.14
15.69%
0.15
4.11%
0.18
17.77%
0.25
40.44%
0.25
1.25%
0.21
15.65%
0.19
9.02%
0.19
0.38%
0.27
38.18%
debt to equity
0.23
-
0.29
24.26%
0.36
24.27%
0.39
9.67%
0.49
24.78%
0.81
64.75%
0.83
2.40%
0.70
15.64%
0.64
8.41%
0.58
10.44%
0.83
44.67%
dividend yield
0.03
-
0.03
6.30%
0.03
8.74%
0.03
6.62%
0.03
2.44%
0.05
89.66%
0.05
2.25%
0.04
10.83%
0.05
6.92%
0.05
5.09%
0.04
27.39%
earnings yield
0.06
-
0.06
3.55%
0.05
7.98%
0.06
13.09%
0.05
11.38%
0.08
55.20%
0.08
6.22%
0.08
4.98%
0.09
9.47%
0.09
0.23%
0.06
33.29%
enterprise value
32.84B
-
40.82B
24.29%
52.27B
28.06%
53.11B
1.61%
67.29B
26.69%
59.40B
11.73%
68.53B
15.37%
64.13B
6.41%
65.84B
2.66%
73.37B
11.44%
91.63B
24.90%
enterprise value over ebitda
7.52
-
7.74
3.02%
8.94
15.47%
8.13
9.03%
9.77
20.13%
6.76
30.83%
6.34
6.24%
5.54
12.65%
5.50
0.57%
6.11
11.03%
8.68
42.04%
ev to operating cash flow
33.74
-
30.56
9.41%
38.74
26.78%
27.28
29.58%
25.40
6.89%
18.95
25.42%
11.38
39.94%
9.37
17.65%
13.01
38.83%
15.47
18.91%
14.75
4.67%
ev to sales
0.42
-
0.44
5.22%
0.50
12.14%
0.44
11.22%
0.51
16.93%
0.37
27.40%
0.37
1.62%
0.33
9.01%
0.31
8.72%
0.32
3.67%
0.35
11.63%
free cash flow per share
0.03
-
0.02
35.40%
-0.14
940.40%
-0.06
53.51%
0.24
471.66%
0.42
76.37%
1.15
174.14%
1.35
16.82%
0.33
75.42%
0.59
78.12%
0.88
48.53%
free cash flow yield
0.00
-
0.00
42.09%
-0.01
796.46%
-0.00
52.68%
0.01
399.04%
0.03
161.60%
0.06
144.59%
0.07
11.77%
0.02
76.25%
0.03
98.50%
0.05
56.71%
graham net net
1.78
-
0.97
45.44%
-0.01
101.12%
-0.93
8,376.77%
-1.72
85.70%
-5.09
195.88%
-6.34
24.36%
-5.76
9.09%
-7.12
23.59%
-2.41
66.13%
-3.07
27.14%
graham number
13.46
-
14.98
11.28%
16.37
9.29%
17.74
8.35%
19.31
8.87%
20.60
6.71%
21.82
5.92%
23.80
9.07%
26.43
11.04%
26.39
0.17%
20.59
21.96%
income quality
0.37
-
0.45
20.45%
0.40
10.17%
0.51
26.75%
0.65
28.42%
0.70
7.78%
1.25
77.20%
1.22
2.05%
0.81
33.94%
0.68
15.90%
1.65
143.11%
intangibles to total assets
0.09
-
0.10
6.96%
0.09
7.11%
0.10
13.84%
0.10
5.23%
0.12
24.83%
0.11
11.53%
0.11
3.10%
0.11
4.44%
0.09
15.75%
0.08
7.40%
interest coverage
7.43
-
5.59
24.77%
6.01
7.54%
6.52
8.50%
5.97
8.47%
4.32
27.57%
6.35
46.92%
5.09
19.91%
5.40
6.21%
5.34
1.26%
4.35
18.53%
interest debt per share
2.40
-
3.21
33.73%
4.23
31.73%
4.88
15.30%
6.56
34.36%
11.60
76.85%
12.71
9.57%
11.67
8.20%
11.67
0.01%
11.54
1.14%
15.91
37.91%
inventory turnover
6.18
-
6.19
0.10%
6.14
0.72%
6.49
5.63%
6.61
1.83%
5.46
17.44%
6.42
17.71%
6.83
6.33%
6.91
1.20%
5.85
15.38%
6.29
7.65%
invested capital
0.23
-
0.29
24.26%
0.36
24.27%
0.39
9.67%
0.49
24.78%
0.81
64.75%
0.83
2.40%
0.70
15.64%
0.64
8.41%
0.58
10.44%
0.83
44.67%
market cap
39.77B
-
44.37B
11.56%
53.54B
20.67%
52.60B
1.76%
65.37B
24.28%
46.43B
28.97%
52.06B
12.13%
54.64B
4.95%
56.54B
3.48%
62.21B
10.02%
62.55B
0.55%
net current asset value
15.20B
-
15.42B
1.40%
15.05B
2.39%
14.36B
4.59%
13.97B
2.68%
12.83B
8.17%
10.45B
18.55%
13.12B
25.52%
12.13B
7.57%
29.38B
142.31%
31.35B
6.72%
net debt to ebitda
-1.59
-
-0.67
57.54%
-0.22
67.83%
0.08
136.50%
0.28
252.74%
1.48
429.03%
1.52
3.21%
0.82
46.17%
0.78
5.16%
0.93
19.58%
2.75
196.36%
net income per share
0.83
-
0.96
15.52%
1.07
11.03%
1.19
11.10%
1.31
10.15%
1.37
4.64%
1.44
5.11%
1.58
9.72%
1.79
13.29%
1.61
10.06%
1.02
36.77%
operating cash flow per share
0.36
-
0.50
37.21%
0.50
1.01%
0.72
44.29%
0.99
36.07%
1.11
12.35%
2.13
92.02%
2.41
13.19%
1.78
26.05%
1.36
23.57%
1.68
23.49%
payables turnover
4.03
-
3.96
1.61%
3.79
4.27%
4.10
8.05%
4.18
1.98%
3.88
7.10%
4.33
11.54%
4.35
0.45%
4.46
2.47%
3.91
12.38%
4.81
23.12%
receivables turnover
4.31
-
3.91
9.08%
3.78
3.36%
3.90
3.05%
3.69
5.21%
3.29
10.90%
3.46
5.06%
3.20
7.40%
3.28
2.28%
3.03
7.59%
3.20
5.85%
research and ddevelopement to revenue
0.01
-
0.01
10.39%
0.01
8.48%
0.01
19.34%
0.01
6.66%
0.01
1.12%
0.01
15.42%
return on tangible assets
0.04
-
0.04
1.83%
0.04
4.65%
0.04
1.24%
0.04
3.98%
0.03
15.74%
0.03
4.19%
0.03
1.58%
0.03
2.83%
0.03
10.72%
0.02
37.76%
revenue per share
29.09
-
34.36
18.12%
39.24
14.20%
44.91
14.45%
48.66
8.35%
56.16
15.40%
65.83
17.23%
67.44
2.44%
75.85
12.47%
66.49
12.34%
70.13
5.47%
roe
0.09
-
0.09
7.77%
0.10
3.21%
0.10
5.16%
0.10
2.35%
0.10
3.84%
0.10
1.53%
0.10
1.20%
0.10
4.09%
0.08
18.83%
0.05
34.35%
roic
0.08
-
0.07
7.27%
0.07
1.80%
0.08
7.81%
0.08
1.91%
0.06
23.41%
0.09
44.70%
0.07
19.77%
0.08
7.41%
0.07
12.69%
0.05
29.90%
sales general and administrative to revenue
0.01
-
0.01
11.51%
0.01
6.95%
0.01
6.88%
0.01
8.98%
0.01
35.65%
0.01
0.52%
0.01
7.08%
0.01
5.09%
0.01
21.01%
0.02
326.60%
shareholders equity per share
9.65
-
10.35
7.20%
11.13
7.58%
11.76
5.66%
12.66
7.62%
13.77
8.82%
14.70
6.74%
15.94
8.42%
17.35
8.84%
19.22
10.81%
18.51
3.68%
stock based compensation to revenue
-0.03
-
tangible asset value
23.82B
-
24.76B
3.98%
27.01B
9.06%
28.22B
4.48%
30.37B
7.61%
30.80B
1.44%
34.45B
11.85%
37.98B
10.23%
41.52B
9.32%
60.08B
44.71%
63.14B
5.09%
tangible book value per share
8.86
-
9.21
3.97%
10.04
9.06%
10.49
4.49%
11.29
7.61%
10.87
3.71%
12.16
11.80%
13.35
9.78%
14.59
9.33%
17.22
18.02%
17.06
0.94%
working capital
16.82B
-
16.66B
0.95%
16.16B
2.98%
19.15B
18.53%
19.01B
0.75%
24.57B
29.23%
23.48B
4.41%
19.43B
17.26%
24.67B
26.97%
38.82B
57.36%
40.06B
3.19%

All numbers in (except ratios and percentages)